These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 25336265)

  • 1. Looking for virtuous promiscuity: electrocardiographic evidence of multichannel drug block.
    Haigney MC
    Clin Pharmacol Ther; 2014 Nov; 96(5):534-6. PubMed ID: 25336265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiating drug-induced multichannel block on the electrocardiogram: randomized study of dofetilide, quinidine, ranolazine, and verapamil.
    Johannesen L; Vicente J; Mason JW; Sanabria C; Waite-Labott K; Hong M; Guo P; Lin J; Sørensen JS; Galeotti L; Florian J; Ugander M; Stockbridge N; Strauss DG
    Clin Pharmacol Ther; 2014 Nov; 96(5):549-58. PubMed ID: 25054430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive T wave morphology assessment in a randomized clinical study of dofetilide, quinidine, ranolazine, and verapamil.
    Vicente J; Johannesen L; Mason JW; Crumb WJ; Pueyo E; Stockbridge N; Strauss DG
    J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25870186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrocardiogram-based index for the assessment of drug-induced hERG potassium channel block.
    Burattini L; Sbrollini A; Scinocca L; Peroni C; Marcantoni I; Morettini M
    J Electrocardiol; 2021; 69S():55-60. PubMed ID: 34736759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone-induced QTc prolongation: is it due to stereoselective block of hERG or to inappropriate QT interval correction?
    Andrássy G; Szabo A
    Clin Pharmacol Ther; 2008 May; 83(5):671; author reply 672. PubMed ID: 18043689
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in global electrical heterogeneity associated with dofetilide, quinidine, ranolazine, and verapamil.
    Stabenau HF; Shen C; Tereshchenko LG; Waks JW
    Heart Rhythm; 2020 Mar; 17(3):460-467. PubMed ID: 31539628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acidification alters antiarrhythmic drug blockade of the ether-a-go-go-related Gene (HERG) Channels.
    Dong DL; Li Z; Wang HZ; Du ZM; Song WH; Yang BF
    Basic Clin Pharmacol Toxicol; 2004 May; 94(5):209-12. PubMed ID: 15125690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of drug-induced hERG potassium-channel block from electrocardiographic T-wave features using artificial neural networks.
    Morettini M; Peroni C; Sbrollini A; Marcantoni I; Burattini L
    Ann Noninvasive Electrocardiol; 2019 Nov; 24(6):e12679. PubMed ID: 31347753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altering extracellular potassium concentration does not modulate drug block of human ether-a-go-go-related gene (hERG) channels.
    Limberis JT; Su Z; Cox BF; Gintant GA; Martin RL
    Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1059-65. PubMed ID: 17042915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid kinetic interactions of ranolazine with HERG K+ current.
    Rajamani S; Shryock JC; Belardinelli L
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):581-9. PubMed ID: 18520952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrocardiographic biomarkers to confirm drug's electrophysiological effects used for proarrhythmic risk prediction under CiPA.
    Vicente J; Hosseini M; Johannesen L; Strauss DG
    J Electrocardiol; 2017; 50(6):808-813. PubMed ID: 28928044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosteric modulators of the hERG K(+) channel: radioligand binding assays reveal allosteric characteristics of dofetilide analogs.
    Yu Z; Klaasse E; Heitman LH; Ijzerman AP
    Toxicol Appl Pharmacol; 2014 Jan; 274(1):78-86. PubMed ID: 24200993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex differences in drug-induced changes in ventricular repolarization.
    Vicente J; Johannesen L; Mason JW; Pueyo E; Stockbridge N; Strauss DG
    J Electrocardiol; 2015; 48(6):1081-7. PubMed ID: 26324176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhythm genes sing more than one tune: noncanonical functions of cardiac ion channels.
    Akhirome E; Jay PY
    Circ Arrhythm Electrophysiol; 2015 Apr; 8(2):261-2. PubMed ID: 25900989
    [No Abstract]   [Full Text] [Related]  

  • 15. Slow junctional rhythm, QTc prolongation and transient torsades de-pointes following combined use of Ivabradine, Diltiazem and Ranolazine.
    Mittal SR
    J Assoc Physicians India; 2014 May; 62(5):426-7. PubMed ID: 25438492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The degree of potassium channel blockade and the risk of torsade de pointes: the truth, nothing but the truth, but not the whole truth.
    Viskin S; Rosovski U
    Eur Heart J; 2005 Mar; 26(6):536-7. PubMed ID: 15713692
    [No Abstract]   [Full Text] [Related]  

  • 17. Serious QT interval prolongation with ranolazine and amiodarone.
    Tarapués M; Cereza G; Arellano AL; Montané E; Figueras A
    Int J Cardiol; 2014 Mar; 172(1):e60-1. PubMed ID: 24424337
    [No Abstract]   [Full Text] [Related]  

  • 18. Electrocardiogram Changes From Ranolazine or From Takotsubo?
    Littmann L
    Am J Med; 2015 Dec; 128(12):e37. PubMed ID: 26592316
    [No Abstract]   [Full Text] [Related]  

  • 19. Ranolazine-induced Repolarization Changes: A Case Report.
    Kumthekar A; Cossarini F; Shih JC; Taub CC; Massera D
    Am J Med; 2015 Jul; 128(7):e3-5. PubMed ID: 25660248
    [No Abstract]   [Full Text] [Related]  

  • 20. The risk of sudden cardiac death in patients with non-ST elevation acute coronary syndrome and prolonged QTc interval: effect of ranolazine.
    Karwatowska-Prokopczuk E; Wang W; Cheng ML; Zeng D; Schwartz PJ; Belardinelli L
    Europace; 2013 Mar; 15(3):429-36. PubMed ID: 23258816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.